Check out the companies making headlines in the midday trading: Tesla – Elon Musk’s electric car company has increased its monthly loss to around 23% with its shares slipping an additional 5.2%. The sale comes after Tesla’s Chinese rival Zeekr said it was rolling out an advanced driver assistance system for free. Meanwhile, RBC Capital Markets has lowered Tesla’s price target amid declining expectations regarding the price of the company’s autonomous driving capabilities. Alphabet – Google’s parent stocks have slid 2.7%. Google said Tuesday it signed a decisive agreement to win a full-speed cash deal for Cloud Security Startup Wiz for $32 billion. The deal is set to be Google’s biggest acquisition ever. Palantir – Stocks slid 4%. Jeffries also reiterated that its stock in defense technology is inadequate, saying the valuation remains a concern. NVIDIA – The chipmaker retreated 3.3% ahead of CEO Jensen Fan’s keynote speech at the GTC AI conference. EV stocks rose 8.8% after the Lucid-Morgan Stanley upgrade was upgraded to equal weight from underweight. Morgan Stanley said lucid has an emerging bull case linked to artificial intelligence. Sarepta Therapeutics – The biotechnology company plummeted 27.4% after disclosing the death of a man treated with elevedi gene therapy. In a statement, Salepta said acute liver damage is a known potential side effect. Eastman Kodak – Stock in film and chemical makers fell 6.4% after the company reported fourth quarter results. Eastman Kodak recorded consolidated revenue of $266 million, reflecting a 3% decline, compared to $275 million in the fourth quarter of 2023. The company reported a surge in net profit for the fourth quarter, but generated net profit of $26 million in quarter. This is up from $5 million in the same period last year. Peabody Energy – The coal mining company said President Donald Trump has raised 6.2% by 6.2% and is using coal to allow energy production after writing on social media platform Truth Social. Willis Towers Watson – Commercial Insurance Stocks went up 2% in the continuation of the UBS upgrade and purchased from Neutral. UBS said the company has improved its operating and free cash flow margins faster than its peers. Millrose Properties – After the company declared dividends and issued new guidance, the residential land developer popped over 10%. Millrose pays shareholders 38 cents per share. It added that it looks at second quarter earnings per share, between 65 cents and 68 cents. HIMS & HERS HEALTH – Digital health stock fell 9.2% after the US Food and Drug Administration shared concerns about unapproved GLP-1 drugs used to lose weight, including combined versions. Hims & Hers began prescribing compound semaglutide last year. – CNBC’s Brian Evans, Pier Singh, Yun Lee and Fred Inbert contributed the report.
TSLA, PLTR, NVDA, HIMS, etc.
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish